M. Tatar And H. Akbulut, "COST-EFFECTIVENESS OF SORAFENIB IN UNRESECTABLE AND/OR METASTATIC RENAL CELL CARCINOMA IN TURKEY," VALUE IN HEALTH , vol.12, no.7, 2009
Tatar, M. And Akbulut, H. 2009. COST-EFFECTIVENESS OF SORAFENIB IN UNRESECTABLE AND/OR METASTATIC RENAL CELL CARCINOMA IN TURKEY. VALUE IN HEALTH , vol.12, no.7 .
Tatar, M., & Akbulut, H., (2009). COST-EFFECTIVENESS OF SORAFENIB IN UNRESECTABLE AND/OR METASTATIC RENAL CELL CARCINOMA IN TURKEY. VALUE IN HEALTH , vol.12, no.7.
Tatar, MEHTAP, And H. Akbulut. "COST-EFFECTIVENESS OF SORAFENIB IN UNRESECTABLE AND/OR METASTATIC RENAL CELL CARCINOMA IN TURKEY," VALUE IN HEALTH , vol.12, no.7, 2009
Tatar, MEHTAP And Akbulut, H.. "COST-EFFECTIVENESS OF SORAFENIB IN UNRESECTABLE AND/OR METASTATIC RENAL CELL CARCINOMA IN TURKEY." VALUE IN HEALTH , vol.12, no.7, 2009
Tatar, M. And Akbulut, H. (2009) . "COST-EFFECTIVENESS OF SORAFENIB IN UNRESECTABLE AND/OR METASTATIC RENAL CELL CARCINOMA IN TURKEY." VALUE IN HEALTH , vol.12, no.7.
@article{article, author={MEHTAP TATAR And author={H. Akbulut}, title={COST-EFFECTIVENESS OF SORAFENIB IN UNRESECTABLE AND/OR METASTATIC RENAL CELL CARCINOMA IN TURKEY}, journal={VALUE IN HEALTH}, year=2009}